Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW 652.00
-15.00 (-2.25%)
Last updated: Jun 26, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Medicine | 62.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine Growth | 93.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Steel | 46.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Steel Growth | 136.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hardfacing | 30.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hardfacing Growth | 124.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
NUKON | 3.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
NUKON Growth | 39.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biosimilar | 3.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biosimilar Growth | -59.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Game | 357.66M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Game Growth | 141.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 3.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 365.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Construction - NUKON | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Construction - NUKON Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Glycholine soft capsule | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Glycholine soft capsule Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Merchandised - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Merchandised - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Foam Glass | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Foam Glass Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Glutanex Injection | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufactured - Glutanex Injection Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service - Dragon Raja Origin | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
South Korea | 131.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 91.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 18.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 96.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|